Alkem Laboratories Limited (ALKEM.NS)

INR 5510.55

(0.32%)

Market Cap (In INR)

658.86 Billion

Revenue (In INR)

126.67 Billion

Net Income (In INR)

17.95 Billion

Avg. Volume

253.21 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4407.05-6439.9
PE
-
EPS
-
Beta Value
0.411
ISIN
INE540L01014
CUSIP
Y0R6P5102
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Vikas Gupta
Employee Count
-
Website
https://www.alkemlabs.com
Ipo Date
2015-12-23
Details
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.